Brain injury markers associated with dysregulated immunological responses in COVID-19

By | December 8, 2021
Study shows that during hospitalization, patients with COVID-19 demonstrated elevated NfL and GFAP in a severity-dependant manner, as well as evidence of ongoing active brain injury 4 months later.